Search research articles
Contact Us
Filters
Showing results (101-110 of 135) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm
W H Wilson, L Sorbara, W D Figg, et al.
Muscle & Nerve
|
July 6, 2001
Thalidomide neuropathy in patients treated for metastatic prostate cancer
F M Molloy, M K Floeter, N A Syed, et al.
Cancer Research
|
April 1, 1994
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer
A Thibault, M R Cooper, W D Figg, et al.
Cancer
|
August 1, 1995
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables
N A Dawson, M R Cooper, W D Figg, et al.
Cancer
|
December 18, 2001
A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar)
S Bates, M Kang, B Meadows, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 2011
Effect of ABCC2 (MRP2) transport function on erythromycin metabolism
R M Franke, C S Lancaster, C J Peer, et al.
Biopharmaceutics & Drug Disposition
|
May 1, 1997
Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatin
W D Figg, M C Christian, R Lush, et al.
Microvascular Research
|
June 30, 2000
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis
A C Berger, H R Alexander, G Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer
A Thibault, D Samid, A C Tompkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
H A Fine, W D Figg, K Jaeckle, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 135) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm
W H Wilson, L Sorbara, W D Figg, et al.
Muscle & Nerve
|
July 6, 2001
Thalidomide neuropathy in patients treated for metastatic prostate cancer
F M Molloy, M K Floeter, N A Syed, et al.
Cancer Research
|
April 1, 1994
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer
A Thibault, M R Cooper, W D Figg, et al.
Cancer
|
August 1, 1995
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables
N A Dawson, M R Cooper, W D Figg, et al.
Cancer
|
December 18, 2001
A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar)
S Bates, M Kang, B Meadows, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 2011
Effect of ABCC2 (MRP2) transport function on erythromycin metabolism
R M Franke, C S Lancaster, C J Peer, et al.
Biopharmaceutics & Drug Disposition
|
May 1, 1997
Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatin
W D Figg, M C Christian, R Lush, et al.
Microvascular Research
|
June 30, 2000
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis
A C Berger, H R Alexander, G Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer
A Thibault, D Samid, A C Tompkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
H A Fine, W D Figg, K Jaeckle, et al.
Page
of 14